Process for the preparation of a propenal intermediate and derivatives thereof
AssigneePharmathen S.A.
InventorsTheoharis V. Koftis, Thanos Andreou, Aristotelis Menisiou, Efstratios Neokosmidis, Asteria Zitrou
Life of this patent
Estimating the term…
Abstract
The present invention provides an improved process for the preparation of (E)-N-(4-(4-fluorophenyl)-6-isopropyl-5-(3-oxoprop-1-enyl)pyrimidin-2-yl)-N-methyl methanesulfon-amide, which is a useful intermediate for the preparation of (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxy hept-6-enoic acid, commonly known as Rosuvastatin.
Claims15
A process for the preparation of (E)-N-(4-(4-fluorophenyl)-6-isopropyl-5-(3-oxoprop-1-enyl)pyrimidin-2-yl)-N-methylmethanesulfonamide of formula I which comprises:
- (a) Treating N-(4-(4-fluorophenyl)-5-formyl-6-isopropylpyrimidin-2-yl)-N-methyl methane-sulfonamide of formula III
- with a compound selected from
- i) an unsaturated compound of formula IV
- wherein R1 and R2 are independently selected from H, alkyl, aryl or a heterocyclic moiety;
- Y is selected from M, MX, BRaRb and MRaRbRc,
- wherein M is selected from alkali, Zn, Mg, Sn and Si;
- X is selected from CI, Br and I;
- Ra, Rb and Rc are independently selected from X, H, C1-C2 alkyl, phenyl and alkoxy;
- and when Y is BRaRb, then Ra and Rb form bidentate alkoxy;
- and
- ii) a compound selected from (R′)2Zn, (R′)2CuLi, (R′)2Cu(CN)Li2, R′R″CuLi or R′R″Cu(CN)Li2,
- wherein R′ is a group of formula V with R1 and R2 having the same structures as defined above, and
- R″ is a heteroaryl group,
- in an inert solvent, optionally in the presence of a promoter, to obtain compound of formula VI:
- (b) oxidative cleavage of the aliphatic carbon-carbon double bond of the obtained compound of formula VI and optionally isolating intermediate of formula VII;
- (c) dehydration of intermediate of formula VII;
- and
- (d) isolation of compound of formula I.
A compound of formula VI, wherein R1 and R2 are independently selected from H, alkyl, aryl or a heterocyclic moiety
A compound of formula VIa, which is N-(4-(4-fluorophenyl)-5-(1-hydroxybut-3-enyl)-6-isopropylpyrimidin-2-yl)-N-methyl methane-sulfonamide
A compound of formula VII, which is N-(4-(4-fluorophenyl)-5-(1-hydroxy-3-oxopropyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide.
Dependencies are inferred from the claim text.